Business
Indrayani Biotech Ltd. Press Release Sep 16 2025
The Company''s Wholly owned subsidiary, IBL Investment Limited, has received approval from SEBI for Category II Alternate Investment Fund Registration
About this update from Indrayani Biotech Ltd.
The Company''s Wholly owned subsidiary, IBL Investment Limited, has received approval from SEBI for Category II Alternate Investment Fund Registration View Attachment
View stock analysis, news, and events for Indrayani Biotech Ltd.